Literature DB >> 9278486

Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.

J Sekiguchi1, S Shuman.   

Abstract

Vaccinia DNA topoisomerase catalyzes the cleavage and re-joining of DNA strands through a DNA-(3'-phosphotyrosyl)-enzyme intermediate formed at a specific target sequence, 5'-(C/T)CCTT downward arrow. The 314 aa protein consists of three protease-resistant structural domains demarcated by protease-sensitive interdomain segments referred to as the bridge and the hinge. The bridge is defined by trypsin-accessible sites at Arg80, Lys83 and Arg84. Photocrosslinking and proteolytic footprinting experiments suggest that residues near the interdomain bridge interact with DNA. To assess the contributions of specific amino acids to DNA binding and transesterification chemistry, we introduced alanine substitutions at 16 positions within a 24 aa segment from residues 63 to 86(DSKGRRQYFYGKMHVQNRNAKRDR). Assays of the rates of DNA relaxation under conditions optimal for the wild-type topoisomerase revealed significant mutational effects at six positions; Arg67, Tyr70, Tyr72, Arg80, Arg84 and Asp85. The mutated proteins displayed normal or near-normal rates of single-turnover transesterification to DNA. The effects of amino acid substitutions on DNA binding were evinced by inhibition of covalent adduct formation in the presence of salt and magnesium. The mutant enzymes also displayed diminished affinity for a subset of cleavage sites in pUC19 DNA. Tyr70 and Tyr72 were subjected to further analysis by replacement with Phe, His, Gln and Arg. At both positions, the aromatic moiety was important for DNA binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278486      PMCID: PMC146948          DOI: 10.1093/nar/25.18.3649

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.

Authors:  S G Morham; S Shuman
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

2.  Site-specific interaction of vaccinia virus topoisomerase I with duplex DNA. Minimal DNA substrate for strand cleavage in vitro.

Authors:  S Shuman
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; J Prescott
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

5.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Site-specific interaction of vaccinia virus topoisomerase I with base and sugar moieties in duplex DNA.

Authors:  S Shuman; J Turner
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

7.  Stimulation of vaccinia topoisomerase I by nucleoside triphosphates.

Authors:  J Sekiguchi; S Shuman
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

8.  Biochemical analysis of mutant alleles of the vaccinia virus topoisomerase I carrying targeted substitutions in a highly conserved domain.

Authors:  N Klemperer; P Traktman
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

9.  Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.

Authors:  C Jaxel; G Capranico; D Kerrigan; K W Kohn; Y Pommier
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

10.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions.

Authors:  J T Stivers; S Shuman; A S Mildvan
Journal:  Biochemistry       Date:  1994-01-11       Impact factor: 3.162

View more
  7 in total

1.  Chemical and traditional mutagenesis of vaccinia DNA topoisomerase provides insights to cleavage site recognition and transesterification chemistry.

Authors:  Lyudmila Yakovleva; Shengxi Chen; Sidney M Hecht; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

2.  Diverse energetic effects of charge reversal mutations of poxvirus topoisomerase IB.

Authors:  Helen Jun; James T Stivers
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

3.  A poxvirus-like type IB topoisomerase family in bacteria.

Authors:  Berit Olsen Krogh; Stewart Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

4.  The genome of Melanoplus sanguinipes entomopoxvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; E Oma; G F Kutish; D L Rock
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB.

Authors:  Benjamin Reed; Lyudmila Yakovleva; Stewart Shuman; Ranajeet Ghose
Journal:  Biochemistry       Date:  2017-06-19       Impact factor: 3.162

6.  Inhibition of Poxvirus Gene Expression and Genome Replication by Bisbenzimide Derivatives.

Authors:  Artur Yakimovich; Moona Huttunen; Benno Zehnder; Lesley J Coulter; Victoria Gould; Christoph Schneider; Manfred Kopf; Colin J McInnes; Urs F Greber; Jason Mercer
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

Review 7.  Structural studies of type I topoisomerases.

Authors:  Nicole M Baker; Rakhi Rajan; Alfonso Mondragón
Journal:  Nucleic Acids Res       Date:  2008-12-23       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.